Report Cover

United States General Anesthesia Drugs Market Report & Forecast 2021-2027


United States General Anesthesia Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K L)
United States General Anesthesia Drugs Market Segment Percentages, By Type, 2020 (%)
    Propofol
    Etomidate
    Midazolam
    Sevoflurane
    Isoflurane
    Others

United States General Anesthesia Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K L)
United States General Anesthesia Drugs Market Segment Percentages, By Application, 2020 (%)
    Intravenous Anesthetics
    Inhalational Anesthetics

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies General Anesthesia Drugs revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies General Anesthesia Drugs revenues share in United States market, 2020 (%)
Key companies General Anesthesia Drugs sales in United States market, 2016-2021 (Estimated), (K L)
Key companies General Anesthesia Drugs sales share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Astrazeneca
    Fresenius-Kabi
    AbbVie
    Baxter Healthcare
    B.Braun
    Maruishi
    Piramal
    Hikma Pharmaceuticals
    Mylan
    Nhwa
    Hengrui
    Lunan
1 Introduction to Research & Analysis Reports
    1.1 General Anesthesia Drugs Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States General Anesthesia Drugs Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States General Anesthesia Drugs Overall Market Size
    2.1 United States General Anesthesia Drugs Market Size: 2021 VS 2027
    2.2 United States General Anesthesia Drugs Revenue, Prospects & Forecasts: 2016-2027
    2.3 United States General Anesthesia Drugs Sales: 2016-2027

3 Company Landscape
    3.1 Top General Anesthesia Drugs Players in United States Market
    3.2 Top United States General Anesthesia Drugs Companies Ranked by Revenue
    3.3 United States General Anesthesia Drugs Revenue by Companies
    3.4 United States General Anesthesia Drugs Sales by Companies
    3.5 United States General Anesthesia Drugs Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 General Anesthesia Drugs Companies in United States Market, by Revenue in 2020
    3.7 Manufacturers General Anesthesia Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 General Anesthesia Drugs Players in United States Market
        3.8.1 List of Tier 1 General Anesthesia Drugs Companies in United States
        3.8.2 List of Tier 2 and Tier 3 General Anesthesia Drugs Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States General Anesthesia Drugs Market Size Markets, 2021 & 2027
        4.1.2 Propofol
        4.1.3 Etomidate
        4.1.4 Midazolam
        4.1.5 Sevoflurane
        4.1.6 Isoflurane
        4.1.7 Others
    4.2 By Type - United States General Anesthesia Drugs Revenue & Forecasts
        4.2.1 By Type - United States General Anesthesia Drugs Revenue, 2016-2021
        4.2.2 By Type - United States General Anesthesia Drugs Revenue, 2022-2027
        4.2.3 By Type - United States General Anesthesia Drugs Revenue Market Share, 2016-2027
    4.3 By Type - United States General Anesthesia Drugs Sales & Forecasts
        4.3.1 By Type - United States General Anesthesia Drugs Sales, 2016-2021
        4.3.2 By Type - United States General Anesthesia Drugs Sales, 2022-2027
        4.3.3 By Type - United States General Anesthesia Drugs Sales Market Share, 2016-2027
    4.4 By Type - United States General Anesthesia Drugs Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States General Anesthesia Drugs Market Size, 2021 & 2027
        5.1.2 Intravenous Anesthetics
        5.1.3 Inhalational Anesthetics
    5.2 By Application - United States General Anesthesia Drugs Revenue & Forecasts
        5.2.1 By Application - United States General Anesthesia Drugs Revenue, 2016-2021
        5.2.2 By Application - United States General Anesthesia Drugs Revenue, 2022-2027
        5.2.3 By Application - United States General Anesthesia Drugs Revenue Market Share, 2016-2027
    5.3 By Application - United States General Anesthesia Drugs Sales & Forecasts
        5.3.1 By Application - United States General Anesthesia Drugs Sales, 2016-2021
        5.3.2 By Application - United States General Anesthesia Drugs Sales, 2022-2027
        5.3.3 By Application - United States General Anesthesia Drugs Sales Market Share, 2016-2027
    5.4 By Application - United States General Anesthesia Drugs Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
    6.1 Astrazeneca
        6.1.1 Astrazeneca Corporation Information
        6.1.2 Astrazeneca Overview
        6.1.3 Astrazeneca General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.1.4 Astrazeneca General Anesthesia Drugs Product Description
        6.1.5 Astrazeneca Recent Developments
    6.2 Fresenius-Kabi
        6.2.1 Fresenius-Kabi Corporation Information
        6.2.2 Fresenius-Kabi Overview
        6.2.3 Fresenius-Kabi General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.2.4 Fresenius-Kabi General Anesthesia Drugs Product Description
        6.2.5 Fresenius-Kabi Recent Developments
    6.3 AbbVie
        6.3.1 AbbVie Corporation Information
        6.3.2 AbbVie Overview
        6.3.3 AbbVie General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.3.4 AbbVie General Anesthesia Drugs Product Description
        6.3.5 AbbVie Recent Developments
    6.4 Baxter Healthcare
        6.4.1 Baxter Healthcare Corporation Information
        6.4.2 Baxter Healthcare Overview
        6.4.3 Baxter Healthcare General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.4.4 Baxter Healthcare General Anesthesia Drugs Product Description
        6.4.5 Baxter Healthcare Recent Developments
    6.5 B.Braun
        6.5.1 B.Braun Corporation Information
        6.5.2 B.Braun Overview
        6.5.3 B.Braun General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.5.4 B.Braun General Anesthesia Drugs Product Description
        6.5.5 B.Braun Recent Developments
    6.6 Maruishi
        6.6.1 Maruishi Corporation Information
        6.6.2 Maruishi Overview
        6.6.3 Maruishi General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.6.4 Maruishi General Anesthesia Drugs Product Description
        6.6.5 Maruishi Recent Developments
    6.7 Piramal
        6.7.1 Piramal Corporation Information
        6.7.2 Piramal Overview
        6.7.3 Piramal General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.7.4 Piramal General Anesthesia Drugs Product Description
        6.7.5 Piramal Recent Developments
    6.8 Hikma Pharmaceuticals
        6.8.1 Hikma Pharmaceuticals Corporation Information
        6.8.2 Hikma Pharmaceuticals Overview
        6.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Product Description
        6.8.5 Hikma Pharmaceuticals Recent Developments
    6.9 Mylan
        6.9.1 Mylan Corporation Information
        6.9.2 Mylan Overview
        6.9.3 Mylan General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.9.4 Mylan General Anesthesia Drugs Product Description
        6.9.5 Mylan Recent Developments
    6.10 Nhwa
        6.10.1 Nhwa Corporation Information
        6.10.2 Nhwa Overview
        6.10.3 Nhwa General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.10.4 Nhwa General Anesthesia Drugs Product Description
        6.10.5 Nhwa Recent Developments
    6.11 Hengrui
        6.11.1 Hengrui Corporation Information
        6.11.2 Hengrui Overview
        6.11.3 Hengrui General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.11.4 Hengrui General Anesthesia Drugs Product Description
        6.11.5 Hengrui Recent Developments
    6.12 Lunan
        6.12.1 Lunan Corporation Information
        6.12.2 Lunan Overview
        6.12.3 Lunan General Anesthesia Drugs Sales and Revenue in United States Market (2016-2021)
        6.12.4 Lunan General Anesthesia Drugs Product Description
        6.12.5 Lunan Recent Developments

7 United States General Anesthesia Drugs Production Capacity, Analysis
    7.1 United States General Anesthesia Drugs Production Capacity, 2016-2027
    7.2 General Anesthesia Drugs Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
    8.1 Market Opportunities & Trends
    8.2 Market Drivers
    8.3 Market Restraints

9 General Anesthesia Drugs Supply Chain Analysis
    9.1 General Anesthesia Drugs Industry Value Chain
    9.2 General Anesthesia Drugs Upstream Market
    9.3 General Anesthesia Drugs Downstream and Clients
    9.4 Marketing Channels Analysis
        9.4.1 Marketing Channels
        9.4.2 General Anesthesia Drugs Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
    11.1 Note
    11.2 Examples of Clients
    11.3 Author Details
    11.4 Disclaimer

List of Tables Table 1. Key Players of General Anesthesia Drugs in United States Market Table 2. Top General Anesthesia Drugs Players in United States Market, Ranking by Revenue (2019) Table 3. United States General Anesthesia Drugs Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States General Anesthesia Drugs Revenue Share by Companies, 2016-2021 Table 5. United States General Anesthesia Drugs Sales by Companies, (K L), 2016-2021 Table 6. United States General Anesthesia Drugs Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers General Anesthesia Drugs Price (2016-2021) & (US$/L) Table 8. Manufacturers General Anesthesia Drugs Product Type Table 9. List of Tier 1 General Anesthesia Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 General Anesthesia Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Propofol Table 12. Major Manufacturers of Etomidate Table 13. By Type - United States General Anesthesia Drugs Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States General Anesthesia Drugs Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States General Anesthesia Drugs Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States General Anesthesia Drugs Sales (K L), 2016-2021 Table 17. By Type - United States General Anesthesia Drugs Sales (K L), 2022-2027 Table 18. By Application - United States General Anesthesia Drugs Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States General Anesthesia Drugs Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States General Anesthesia Drugs Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States General Anesthesia Drugs Sales (K L), 2016-2021 Table 22. By Application - United States General Anesthesia Drugs Sales (K L), 2022-2027 Table 23. Astrazeneca Corporation Information Table 24. Astrazeneca Description and Major Businesses Table 25. Astrazeneca General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 26. Astrazeneca General Anesthesia Drugs Product Table 27. Astrazeneca Recent Developments Table 28. Fresenius-Kabi Corporation Information Table 29. Fresenius-Kabi Description and Major Businesses Table 30. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 31. Fresenius-Kabi General Anesthesia Drugs Product Table 32. Fresenius-Kabi Recent Developments Table 33. AbbVie Corporation Information Table 34. AbbVie Description and Major Businesses Table 35. AbbVie General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 36. AbbVie General Anesthesia Drugs Product Table 37. AbbVie Recent Developments Table 38. Baxter Healthcare Corporation Information Table 39. Baxter Healthcare Description and Major Businesses Table 40. Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 41. Baxter Healthcare General Anesthesia Drugs Product Table 42. Baxter Healthcare Recent Developments Table 43. B.Braun Corporation Information Table 44. B.Braun Description and Major Businesses Table 45. B.Braun General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 46. B.Braun General Anesthesia Drugs Product Table 47. B.Braun Recent Developments Table 48. Maruishi Corporation Information Table 49. Maruishi Description and Major Businesses Table 50. Maruishi General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 51. Maruishi General Anesthesia Drugs Product Table 52. Maruishi Recent Developments Table 53. Piramal Corporation Information Table 54. Piramal Description and Major Businesses Table 55. Piramal General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 56. Piramal General Anesthesia Drugs Product Table 57. Piramal Recent Developments Table 58. Hikma Pharmaceuticals Corporation Information Table 59. Hikma Pharmaceuticals Description and Major Businesses Table 60. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 61. Hikma Pharmaceuticals General Anesthesia Drugs Product Table 62. Hikma Pharmaceuticals Recent Developments Table 63. Mylan Corporation Information Table 64. Mylan Description and Major Businesses Table 65. Mylan General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 66. Mylan General Anesthesia Drugs Product Table 67. Mylan Recent Developments Table 68. Nhwa Corporation Information Table 69. Nhwa Description and Major Businesses Table 70. Nhwa General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 71. Nhwa General Anesthesia Drugs Product Table 72. Nhwa Recent Developments Table 73. Hengrui Corporation Information Table 74. Hengrui Description and Major Businesses Table 75. Hengrui General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 76. Hengrui General Anesthesia Drugs Product Table 77. Hengrui Recent Developments Table 78. Lunan Corporation Information Table 79. Lunan Description and Major Businesses Table 80. Lunan General Anesthesia Drugs Sales (K L), Revenue (US$, Mn) and Gross Margin (US$/L) (2016-2021) Table 81. Lunan General Anesthesia Drugs Product Table 82. Lunan Recent Developments Table 83. General Anesthesia Drugs Production Capacity (K L) of Key Manufacturers in United States Market, 2019-2021 (K L) Table 84. United States General Anesthesia Drugs Capacity Market Share of Key Manufacturers, 2019-2021 Table 85. General Anesthesia Drugs Market Opportunities & Trends in United States Market Table 86. General Anesthesia Drugs Market Drivers in United States Market Table 87. General Anesthesia Drugs Market Restraints in United States Market Table 88. General Anesthesia Drugs Raw Materials Table 89. General Anesthesia Drugs Raw Materials Suppliers in United States Market Table 90. Typical General Anesthesia Drugs Downstream Table 91. General Anesthesia Drugs Downstream Clients in United States Market Table 92. General Anesthesia Drugs Distributors and Sales Agents in United States Market List of Figures Figure 1. General Anesthesia Drugs Product Picture Figure 2. General Anesthesia Drugs Segment by Type Figure 3. General Anesthesia Drugs Segment by Application Figure 4. United States General Anesthesia Drugs Market Overview: 2020 Figure 5. United States General Anesthesia Drugs Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States General Anesthesia Drugs Revenue, 2016-2027 (US$, Mn) Figure 7. General Anesthesia Drugs Sales in United States Market: 2016-2027 (K L) Figure 8. The Top 3 and 5 Players Market Share by General Anesthesia Drugs Revenue in 2020 Figure 9. Propofol Product Picture Figure 10. Etomidate Product Picture Figure 11. Midazolam Product Picture Figure 12. Sevoflurane Product Picture Figure 13. Isoflurane Product Picture Figure 14. By Type - United States General Anesthesia Drugs Sales Market Share, 2016-2027 Figure 15. By Type - United States General Anesthesia Drugs Revenue Market Share, 2016-2027 Figure 16. By Type - United States General Anesthesia Drugs Price (US$/L), 2016-2027 Figure 17. Intravenous Anesthetics Figure 18. Inhalational Anesthetics Figure 19. By Application - United States General Anesthesia Drugs Sales Market Share, 2016-2027 Figure 20. By Application - United States General Anesthesia Drugs Revenue Market Share, 2016-2027 Figure 21. By Application - United States General Anesthesia Drugs Price (US$/L), 2016-2027 Figure 22. Astrazeneca General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Fresenius-Kabi General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. AbbVie General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. Baxter Healthcare General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. B.Braun General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Maruishi General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Piramal General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. Hikma Pharmaceuticals General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. Mylan General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 31. Nhwa General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 32. Hengrui General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 33. Lunan General Anesthesia Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 34. United States General Anesthesia Drugs Production Capacity (K L), 2016-2027 Figure 35. General Anesthesia Drugs Industry Value Chain Figure 36. Marketing Channels

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us